Search

Author/Creator Weisberger, Annemarie

1. 2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. (October 2021)

Authors:
Marlow, Neil; Stahl, Andreas; Lepore, Domenico; Fielder, Alistair; Reynolds, James D; Zhu, Qi; Weisberger, Annemarie; Stiehl, Daniel P; Fleck, Brian
Journal:
Lancet
Issue:
Volume 5:Number 10(2021)
Page Start:
698
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Two different treatment regimens of ranibizumab 0.5 mg for neovascular age‐related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study. Issue 3 (30th December 2020)

Authors:
Li, Xiaoxin; Zhu, Qi; Egger, Anna; Chang, Liu; Wolf, Sebastian; Song, Yanping; Zhang, Junjun; Dong, Fangtian; Xu, Xun; Weisberger, Annemarie
Journal:
Acta ophthalmologica
Issue:
Volume 99:Issue 3(2021)
Page Start:
e336
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search